Home
Write a Paper
Library
Editorial Board
Events
Bookstore
Back Issues
Buy Reports
Subscribe
We use necessary cookies to make our site work. We'd also like to set analytics cookies that help us make improvements by measuring how you use the site. For more detailed information about the cookies we use, see our Cookies page.
Learn More
Accept
Library
Compliance Red Flags: What Companies Should Look Out For in Times of Change
Fabiana Lacerca-Allen, SVP Compliance, Aimmune Therapeutics, USA
Implementing a Robust Compliance Program in a Remote Environment
Fabiana Lacerca-Allen, SVP Compliance, Aimmune Therapeutics, USA
Managing Compliance Risk in a COVID and Post-COVID World
Fabiana Lacerca-Allen, SVP Compliance, Aimmune Therapeutics, USA
Next-Level Compliance: What Every Board Member Should Know
Fabiana Lacerca-Allen, President, Ethiprax, USA
United States Jurisdiction Abroad
Fabiana Lacerca, Senior Vice President and Chief Compliance Officer, Elan Pharmaceuticals, USA
What Makes a Great Compliance Leader?
Fabiana Lacerca-Allen, SVP Compliance, Aimmune Therapeutics, USA
Want to have access to
great content?
Subscribe to the International In-House Counsel Journal and be the first to hear
Sign up